ContextLogic Inc - Ordinary Shares - Class A
LOGC
Market Cap$133.73M
Close$
$4.59
15.9% downside
Current Fair Value
15.9% downsideOvervalued by 15.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $133.73 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-11.96 |
| Beta | 0.0 |
| Outstanding Shares | 24,492,300 |
| Avg 30 Day Volume | 590,287 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About LogicBio Therapeutics Inc
39 employees
CEO: Frederic Chereau LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a...